{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:56:43Z","timestamp":1768262203578,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cjca.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T22:44:07Z","timestamp":1522363447000},"page":"1041-1047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Hassan","family":"Hazari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Belenkie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Kryski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tak","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navdeep","family":"Dehar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aneal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2018.03.011_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS: Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cjca.2018.03.011_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cjca.2017.04.015","article-title":"Clinical features, diagnosis, and management of patients with Anderson-Fabry cardiomyopathy","volume":"33","author":"Yogasundaram","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2009.08.002","article-title":"Cardiac challenges in patients with Fabry disease","volume":"141","author":"Weidemann","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mhj.2000.105105","article-title":"New insights in cardiac structural changes in patients with Fabry's disease","volume":"139","author":"Linhart","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2018.03.011_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/eurheartj\/ehp588","article-title":"Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity","volume":"31","author":"Wu","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.03.011_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0735-1097(86)80238-8","article-title":"Echocardiographic abnormalities and disease severity in Fabry's disease","volume":"7","author":"Goldman","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib7","article-title":"Enzyme replacement therapy for Anderson-Fabry disease","volume":"7","author":"El Dib","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2018.03.011_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10545-014-9717-4","article-title":"Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study","volume":"37","author":"Anderson","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2018.03.011_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymgmr.2015.02.002","article-title":"Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: a Fabry Outcome Survey analysis","volume":"3","author":"Beck","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.cjca.2018.03.011_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2008.03.007","article-title":"Onset and progression of the Anderson-Fabry disease-related cardiomyopathy","volume":"130","author":"Kampmann","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/gim.2013.53","article-title":"Analysis of left ventricular mass in untreated men and in men treated with agalsidase-beta: data from the Fabry registry","volume":"15","author":"Germain","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2018.03.011_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","article-title":"Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease","volume":"101","author":"Patel","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2018.03.011_bib13","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.echo.2015.06.009","article-title":"Discrepancies in left ventricular mass calculation based on echocardiography and cardiovascular magnetic resonance measurements in patients with left ventricular hypertrophy","volume":"28","author":"Seo","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2018.03.011_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","article-title":"Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis, effectiveness of ERT in different disease stages","volume":"37","author":"Rombach","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.cjca.2018.03.011_bib15","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1046\/j.1523-1755.1999.00786.x","article-title":"Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging","volume":"56","author":"Stewart","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.cjca.2018.03.011_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00004872-199608000-00011","article-title":"Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension","volume":"14","author":"Missouris","year":"1996","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2018.03.011_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ymgme.2014.01.014","article-title":"Outcomes of patients treated through the Canadian Fabry disease initiative","volume":"111","author":"Sirrs","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2018.03.011_bib18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2018.03.011_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man: anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.03.011_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","article-title":"Simplified calculation of body-surface area","volume":"317","author":"Mosteller","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2018.03.011_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2018.03.011_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12968-015-0114-4","article-title":"A\u00a0disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease","volume":"17","author":"Kozor","year":"2015","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjca.2018.03.011_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mrm.25166","article-title":"Quantification of circumferential, longitudinal, and radial global fractional shortening using steady-state free precession cines: a comparison with tissue-tracking strain and application in Fabry disease","volume":"73","author":"Cheng-Baron","year":"2015","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.cjca.2018.03.011_bib24","series-title":"Practical Statistics for Medical Research","first-page":"611","volume":"xii","author":"Altman","year":"1999"},{"key":"10.1016\/j.cjca.2018.03.011_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.cjca.2018.03.011_bib26","series-title":"Psychometric Theory","first-page":"701","volume":"xv","author":"Nunnally","year":"1978"},{"key":"10.1016\/j.cjca.2018.03.011_bib27","doi-asserted-by":"crossref","first-page":"1221.e1","DOI":"10.1016\/j.cjca.2015.10.033","article-title":"Evaluation of proinflammatory prognostic biomarkers for Fabry cardiomyopathy with enzyme replacement therapy","volume":"32","author":"Chen","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.03.011_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.cjca.2018.03.011_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.cjca.2018.03.011_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ymgme.2009.11.001","article-title":"Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative","volume":"99","author":"Sirrs","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2018.03.011_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00004872-199816080-00015","article-title":"Clinical impact of various geometric models for calculation of echocardiographic left ventricular mass","volume":"16","author":"de Simone","year":"1998","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2018.03.011_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jcmg.2012.06.003","article-title":"LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2018.03.011_bib34","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.CIR.0000142670.65971.5F","article-title":"Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging","volume":"110","author":"Mor-Avi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.03.011_bib35","unstructured":"Sirrs SB, Daniel G, Iwanochko R, et\u00a0al. Canadian Fabry Disease Treatment Guidelines. 2016. Available at: http:\/\/www.garrod.ca\/wp-content\/uploads\/Canadian-FD-Treatment-Guidelines-2017.pdf. Accessed May 31, 2018."},{"key":"10.1016\/j.cjca.2018.03.011_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2018.03.011_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2018.03.011_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2015.10.140","article-title":"Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy","volume":"203","author":"Yano","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2018.03.011_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J\u00a0Cardiovasc Magn Reson"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18302459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18302459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T02:30:40Z","timestamp":1532399440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X18302459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0828282X18302459"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2018.03.011","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Cardiac Magnetic Resonance Imaging and Echocardiography in Assessment of Left Ventricular Hypertrophy in Fabry Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}